Complementary therapy: perceptions of older people with lung or colorectal cancer

Abstract

Patients should be offered high quality written information on CT services to enable choice, improve knowledge, and promote wider access. Increased physician education may facilitate provision of such information.

Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients

“… 6 Other therapeutic procedures include radiotherapy and complementary therapies in palliative and hospice care, usually with disappointing results. 3 , 7 , 8 Moreover, the therapeutic methods for elderly patients with NSCLC and patients with poor performance status are always limited because these patients are not eligible for aggressive therapies due to the age-related reduction in the functional reserve of many organs and the presence of comorbidities. 3 , 8 IFCT-0501, the largest Phase III randomized trial dedicated to elderly patients with advanced NSCLC, demonstrated only a 6.2-month median overall survival (OS) and 25.4% 1-year survival for vinorelbine or gemcitabine monotherapy in elderly patients.…”